Tag:
Pharmaxis Ltd.
Latest Headlines
Latest Headlines
Pharmaxis-supported study shows potential for inhaled powder CF treatment
Adding a new long-term inhaled dry powder version of mannitol to standard therapy helps improve lung function in cystic fibrosis patients for up to a year, according to a new study. But the forced
